Market Wire - Versartis Long-Term Preclinical Safety Data for VRS-317 Presented at ENDO 2011
Posted by admin / Under Human Growth HormoneJune 5, 2011 --
Versartis, Inc., an emerging biotechnology company developing novel therapeutics for patients with endocrine disorders, today presented new...
Published on Sunday 5th of February 2012 01:19:03 AM
Read more...
